0001209191-19-053541.txt : 20191017 0001209191-19-053541.hdr.sgml : 20191017 20191017201535 ACCESSION NUMBER: 0001209191-19-053541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191015 FILED AS OF DATE: 20191017 DATE AS OF CHANGE: 20191017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weiss Patrick CENTRAL INDEX KEY: 0001755793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 191156492 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-15 1 0001581280 Twist Bioscience Corp TWST 0001755793 Weiss Patrick C/O TWIST BIOSCIENCE CORPORATION 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 0 1 0 0 SVP, R&D GM Data Storage Common Stock 2019-10-15 4 M 0 3702 5.95 A 108989 D Common Stock 2019-10-15 4 M 0 3662 8.82 A 112651 D Common Stock 2019-10-15 4 S 0 40 22.82 D 112611 D Common Stock 2019-10-15 4 S 0 3662 23.335 D 108949 D Common Stock 2019-10-15 4 S 0 3662 23.342 D 105287 D Common Stock 2019-10-16 4 M 0 3682 5.95 A 108969 D Common Stock 2019-10-16 4 M 0 3682 8.82 A 112651 D Common Stock 2019-10-16 4 S 0 1872 23.578 D 110779 D Common Stock 2019-10-16 4 S 0 1810 24.34 D 108969 D Common Stock 2019-10-16 4 S 0 1884 23.593 D 107085 D Common Stock 2019-10-16 4 S 0 1798 24.338 D 105287 D Employee Stock Option (right to buy) 5.95 2019-10-15 4 M 0 3702 0.00 D 2025-09-28 Common Stock 3702 14617 D Employee Stock Option (right to buy) 8.82 2019-10-15 4 M 0 3662 0.00 D 2027-09-28 Common Stock 3662 70602 D Employee Stock Option (right to buy) 5.95 2019-10-16 4 M 0 3682 0.00 D 2025-09-28 Common Stock 3682 10935 D Employee Stock Option (right to buy) 8.82 2019-10-16 4 M 0 3682 0.00 D 2027-09-28 Common Stock 3682 66920 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Represents the aggregate of sales effected on the same day at different prices. Represents the weighted average sales price per share. The shares sold at prices ranging from $22.81 to $23.70 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $23.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.48 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $23.20 to $24.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. The option is immediately exercisable. 10% of the shares subject to the option vested on September 29, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for Patrick Weiss 2019-10-17